Evidence map›Paper›PMID 36733525›Full record

ArticlePharmacy practice

Retrospective cohort study on risk factors for developing ischemic stroke.

Adel Sadeq, Mohamed A Baraka, Amar Hamrouni, Asim Ahmed Elnour

Abstract read
In one paragraph

Article in Pharmacy practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Adel SadeqPhD, MSc. Assistant Professor, Program of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain-UAE, United Arab Emirates. adel.sadeq@aau.ac.ae.ORCID https://orcid.org/0000-0001-9529-8898
Mohamed A BarakaPhD, MSc. Assistant professor, Clinical Pharmacy department, College of Pharmacy, Al Ain University, Al Ain campus, United Arab Emirates, Assistant professor, Clinical Pharmacy department, College of Pharmacy, Al-Azhar University, Cairo, Egypt. mohamed. baraka@aau.ac.ae, mohamed.baraka2020@gmail.com.ORCID https://orcid.org/0000-0002-7645-2420
Amar HamrouniPhD, MSc. Assistant Professor, Program of Clinical Pharmacy, College of Pharmacy, Al Ain University, Al Ain-UAE, United Arab Emirates. Amar.Hamrouni@aau.ac.ae.ORCID https://orcid.org/0000-0002-8283-5364
Asim Ahmed ElnourPhD, MSc. Program of Clinical Pharmacy, College of Pharmacy, AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.asim.ahmed@aau.ac.ae.ORCID https://orcid.org/0000-0002-4143-7810

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is a paucity of studies describing the risk factors for developing ischemic stroke in our region. Objective: The objective of the current study was to delineate the potential risk factors for the development of ischemic stroke. Methods: We have conducted a retrospective cohort hospitalbased study that has enrolled 231 subjects. The subjects have had presented to the emergency department in a tertiary hospital in the United Arab Emirates. Subjects were diagnosed with ischemic stroke within 24 hours of presentation. Outcome measure: The main outcome measure was the development of ischemic stroke during an indexed hospital visit. Results: The mean age was 47.5 ±3.2 with a higher preponderance of males over females (60.9%) and 48.1% were ≥ 65 years. The final logistic regression model for the development of ischemic stroke contains seven variables. In descending order, the seven predictive risk factors for the development of ischemic stroke were: hypertension (OR 6.1, CI 2.4-9.5; P = 0.029), coronary artery disease (OR 4.2, 3.7-9.1; P = 0.038), low physical activity (OR 4.2, CI 2.1-9.1; P = 0.035), history of previous stroke (OR 4.1, 1.4-3.4; P = 0.033), atrial fibrillation (OR 3.2, CI 2.6-8.2; P = 0.017), family history of stroke (OR 3.1, 1.3-6.9; P = 0.042) and diabetes mellitus (OR 2.7, CI 1.25-6.1; P = 0.035). The specificity of the model was 58.1%; the sensitivity was 86.1%, and the overall accuracy was 75.7%. Conclusion: It is prudent to control modifiable risk factors for the development of strokes such as hypertension, diabetes, atrial fibrillation, coronary artery disease, and low physical activity.

Indexed as

Ischemic strokeModelModifiable and non-modifiablePredictorsRisk factors

Identifiers

PMID36733525
PMCPMC9851832

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.